Meniscus injuries indicated for meniscectomy
Conditions
Interventions
A single injection of human autologous synovial stem cells under arthroscopy
Sponsors
Sakurai Tsutomu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with suspected meniscus flap tear 2.Patients with knee pain 3.Patients with one or more of the following symptoms Feeling stuck in the knee Instability of the knee Knee range of motion impairment Knee joint edema 4.Other
Exclusion criteria
Exclusion criteria: 1.Patients with poor knee alignment 2.Patients who underwent meniscus surgery or platelet rich plasma therapy 3.Patients with or history of knee ligament injury 4.Diabetic patients with poor glycemic control 5.Patients with the following complications and poor general condition Severe cardiovascular disease Severe liver disease Severe renal dysfunction Severe anemia uncontrolled mental illness Other diseases for which sudden change or worsening of symptoms can be expected during study participation 6.Patients who are pregnant or possibly pregnant and/or breast-feeding, or patients planning to become pregnant during the study period 7.Other
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Lysholm score after injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Arthroscopic assesment of the meniscus before and 52 weeks after injection of FF-31501 Changes in KOOS after injection Changes in NRS after injection | — |
Contacts
Public ContactOfficer Clinical Trial Information
FUJIFILM Toyama Chemical Co., Ltd
Outcome results
None listed